RESULT_COUNT: 284,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Host Third Quarter 2017 Investor Update Call,2017-10-19 20:01:00 +0000,https://finance.yahoo.com/news/ironwood-pharmaceuticals-host-third-quarter-200100308.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. today announced it will host its third quarter 2017 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, November 2, 2017."
IRWD,IRWD:UW,BBG000GBZJP0,See what the IHS Markit Score report has to say about Ironwood Pharmaceuticals Inc.,2017-10-17 12:04:56 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120456014.html?.tsrc=rss,"Short interest is high for IRWD with between 15 and 20% of shares on loan.  This means that investors who seek to profit from falling equity prices are currently targeting IRWD.  Over the last month, growth of ETFs holding IRWD is favorable, with net inflows of $4.03 billion."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : October 16, 2017",2017-10-16 14:07:45 +0000,http://finance.yahoo.com/r/6b1e4524-0cd0-35aa-98dc-106496e80ef7/ironwood-pharmaceuticals-inc-value-analysis-nasdaqirwd-october-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Ironwood Pharmaceuticals, Inc. a score of 47. Our analysis is based on comparing Ironwood Pharmaceuticals, Inc. with the following peers – Progenics Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. (PGNX-US, SGYP-US, ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : October 16, 2017",2017-10-16 13:54:54 +0000,http://finance.yahoo.com/r/ebb0558b-fc82-326f-8e25-5295d0c49c69/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-october-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Presenting Linaclotide Data at the World Congress of Gastroenterology at ACG 2017,2017-10-16 12:00:00 +0000,https://finance.yahoo.com/news/ironwood-pharmaceuticals-presenting-linaclotide-data-120000384.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, today announced that the company and its collaborators are presenting clinical data for linaclotide at the World Congress of Gastroenterology at the American College of Gastroenterology , on October 13-18, 2017 in Orlando, Florida."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : October 13, 2017",2017-10-13 12:36:08 +0000,http://finance.yahoo.com/r/b549b793-21b8-341e-98cc-16466263d440/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-irwd-us-october-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Ironwood Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,"Ardelyx IBS-C Candidate Succeeds in Pivotal Study, Stock Up",2017-10-12 16:17:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PqXzKaEnAqg/ardelyx-ibs-c-candidate-succeeds-in-pivotal-study-stock-up-cm858783,Ardelyx Inc ARDX announced meeting the primary endpoint in a second phase III study T3MPO 2 evaluating tenapanor in patients with irritable bowel syndrome with constipation IBS C Based on the positive top line data from this study as well as previously completed T3MPO 1 study
IRWD,IRWD:UW,BBG000GBZJP0,Don’t Miss Out On These Tantalizing Sohn Conference Stock Pitches,2017-10-09 13:30:26 +0000,http://finance.yahoo.com/r/9ecd2813-4d79-3c19-b2d3-ef818dd1b474/dont-miss-out-on-these-tantalizing-sohn-conference-stock-pitches-602910?yptr=yahoo&.tsrc=rss,"The Sohn and Next Wave Sohn Conferences took place in San Francisco last week, shining the spotlight on several growing and established hedge funds, who shared some of their best ideas with attendees. Last year’s event raised $320,000 for San Francisco’s underprivileged youth, providing them with educational opportunities. Among the hedge funds tracked by Insider […]"
IRWD,IRWD:UW,BBG000GBZJP0,IRWD Makes Bullish Cross Above Critical Moving Average,2017-10-05 16:50:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/arBtyDBD4Rg/irwd-makes-bullish-cross-above-critical-moving-average-cm855854,In trading on Thursday shares of Ironwood Pharmaceuticals Inc Symbol IRWD crossed above their 200 day moving average of 16 65 changing hands as high as 17 66 per share Ironwood Pharmaceuticals Inc shares are currently trading up about 2 8 on the day The chart below shows the one
IRWD,IRWD:UW,BBG000GBZJP0,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : October 3, 2017",2017-10-03 15:20:00 +0000,http://finance.yahoo.com/r/46152433-4a3c-3b98-852b-c383057bebb1/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-october-3-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,See what the IHS Markit Score report has to say about Ironwood Pharmaceuticals Inc.,2017-10-02 12:03:32 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120332823.html?.tsrc=rss,Short interest is moderately high for IRWD with between 10 and 15% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
IRWD,IRWD:UW,BBG000GBZJP0,Why Synergy Pharmaceuticals Rallied 12% Today,2017-09-29 22:33:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kf8xD1UZt78/why-synergy-pharmaceuticals-rallied-12-today-cm853327,What happened Synergy Pharmaceuticals NASDAQ SGYP updated investors on the performance of its chronic idiopathic constipation CIC drug Trulance at the Ladenburg Thalmann Healthcare Conference on Sept 26 and the Cantor Fitzgerald global healthcare conference on Sept 27
IRWD,IRWD:UW,BBG000GBZJP0,See what the IHS Markit Score report has to say about Ironwood Pharmaceuticals Inc.,2017-09-28 12:03:46 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120346151.html?.tsrc=rss,Short interest is moderately high for IRWD with between 10 and 15% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
IRWD,IRWD:UW,BBG000GBZJP0,See what the IHS Markit Score report has to say about Ironwood Pharmaceuticals Inc.,2017-09-27 12:02:34 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120234819.html?.tsrc=rss,Short interest is moderately high for IRWD with between 10 and 15% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : IRWD-US : September 26, 2017",2017-09-26 12:12:39 +0000,http://finance.yahoo.com/r/302f2b9b-5557-31fb-8a27-e3f82bd3dcec/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-irwd-us-september-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Ironwood Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : September 13, 2017",2017-09-13 22:42:15 +0000,http://finance.yahoo.com/r/beddec84-8189-3291-8ede-ab06d2c0dbdc/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-september-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017",2017-09-11 18:43:43 +0000,http://finance.yahoo.com/r/27e3dc6d-d3cc-3912-9320-7dbdd5db6635/ironwood-pharmaceuticals-inc-irwd-us-earnings-analysis-q2-2017-by-the-numbers-september-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Ironwood Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Ironwood Pharmaceuticals, Inc. – Progenics Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,New Drugs Approved In August,2017-09-07 05:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZoP1iaTzo4w/new-drugs-approved-in-august-20170907-00189,New Drugs Approved In August
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Announces Leadership Change,2017-09-06 12:00:00 +0000,https://finance.yahoo.com/news/ironwood-pharmaceuticals-announces-leadership-change-120000278.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. announced today that Tom Graney, chief financial officer and senior vice president, finance and corporate strategy will leave the company, effective September 13, 2017, to pursue another opportunity."
IRWD,IRWD:UW,BBG000GBZJP0,Why Is Ironwood (IRWD) Down 4.1% Since the Last Earnings Report?,2017-09-04 13:51:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gNdjO0RADGQ/why-is-ironwood-irwd-down-41-since-the-last-earnings-report-cm840721,About a month has gone by since the last earnings report for Ironwood Pharmaceuticals Inc IRWD Shares have lost about 4 1 in that time frame underperforming the market Will the recent negative trend continue leading up to the next earnings release or is it due for a breakout Before
IRWD,IRWD:UW,BBG000GBZJP0,Why Is Ironwood (IRWD) Down 4.1% Since the Last Earnings Report?,2017-09-04 11:22:11 +0000,https://finance.yahoo.com/news/why-ironwood-irwd-down-4-112211943.html?.tsrc=rss,Ironwood (IRWD) reported earnings about a month ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences,2017-08-31 20:01:00 +0000,https://finance.yahoo.com/news/ironwood-pharmaceuticals-present-upcoming-september-200100211.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. will present corporate updates at two upcoming investor conferences in September:"
IRWD,IRWD:UW,BBG000GBZJP0,Look Under The Hood: VTWG Has 11% Upside,2017-08-31 14:49:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kDMsmpSFUcI/look-under-the-hood-vtwg-has-11-upside-cm839621,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
IRWD,IRWD:UW,BBG000GBZJP0,Interesting IRWD Put And Call Options For October 20th,2017-08-23 17:40:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SZQXmeermKs/interesting-irwd-put-and-call-options-for-october-20th-cm836106,Investors in Ironwood Pharmaceuticals Inc Symbol IRWD saw new options begin trading this week for the October 20th expiration At Stock Options Channel our YieldBoost formula has looked up and down the IRWD options chain for the new October 20th contracts and identified one put and one
IRWD,IRWD:UW,BBG000GBZJP0,Today's Research Reports on Stocks to Watch: Medtronic and Ironwood Pharmaceuticals,2017-08-23 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000121.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 23, 2017 / Shares of Ironwood Pharmaceuticals exploded on Tuesday after the company announced that its Duzallo drug had been approved by the FDA and that it is now the ..."
IRWD,IRWD:UW,BBG000GBZJP0,See what the IHS Markit Score report has to say about Ironwood Pharmaceuticals Inc.,2017-08-23 12:02:27 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120227850.html?.tsrc=rss,Ironwood Pharmaceuticals Inc NASDAQ/NGS:IRWD
IRWD,IRWD:UW,BBG000GBZJP0,"Biotech Stock Roundup: EU Label Expansion for Alexion, BIIB Facing Drug Price Probe",2017-08-23 11:56:11 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-eu-label-115611574.html?.tsrc=rss,Key highlights include regulatory approvals for companies like Alexion (ALXN) and Ironwood while Biogen is one of the companies facing an investigation into the pricing of multiple sclerosis drugs.
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharma's Combination Gout Drug Gets FDA Approval,2017-08-22 16:41:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kvtlvf1_UFI/ironwood-pharmas-combination-gout-drug-gets-fda-approval-cm835414,Ironwood Pharmaceuticals Inc IRWD announced that the FDA has approved its oral fixed dose combination drug Duzallo for the treatment of hyperuricemia in patients with uncontrolled gout Duzallo is a once daily fixed dose combination of Ironwood s gout drug Zurampic lesinurad and
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharma&apos;s Combination Gout Drug Gets FDA Approval,2017-08-22 14:46:02 +0000,https://finance.yahoo.com/news/ironwood-pharma-apos-combination-gout-144602577.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. (IRWD) announced that the FDA has approved Duzallo for the treatment of hyperuricemia in patients with uncontrolled gout."
IRWD,IRWD:UW,BBG000GBZJP0,"FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed",2017-08-22 01:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4wjgdJDoGlA/fda-approves-irwds-gout-drug-its-a-thumbs-up-for-alxn-in-eu-crme-crushed-20170822-00025,"FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood gets FDA approval for new drug for gout,2017-08-21 16:50:43 +0000,http://finance.yahoo.com/r/7e6149d7-6038-3c96-bccc-7e4fc3d0cdff/ironwood-gets-fda-approval-for-new-drug-for-gout.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Cambridge-based Ironwood Pharmaceuticals has gotten U.S. approval to sell its treatment for a condition associated with gout, called hyperuricemia.  The oral drug, called Duzallo, helps patients with the highly symptomatic and painful form of inflammatory arthritis caused by elevated levels of uric acid in the blood.  The current method of treatment, a generic drug by the name of allopurinol, is able to successfully treat approximately a quarter of the 8 million patients with gout in the U.S, Ironwood’s (IRWD) new combination therapy will be able to treat about half of them."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharma Muted Despite FDA Approval,2017-08-21 15:38:45 +0000,https://finance.yahoo.com/news/ironwood-pharma-muted-despite-fda-153845379.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) shares remained relatively muted on Monday after the firm announced a key U.S. Food and Drug Administration (FDA) approval for its gout treatment duzallo. ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Shares Jump on FDA Approval for Hyperuricemia Drug - Biotech Movers,2017-08-21 13:33:00 +0000,http://finance.yahoo.com/r/9b7cecea-85e0-30d6-9c72-72f2bc21733a/ironwood-shares-jump-on-fda-approval-for-hyperuricemia-drug-biotech-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Cambridge, Mass.-based firm clinched FDA approval for hyperuricemia drug Duzallo."
IRWD,IRWD:UW,BBG000GBZJP0,FDA approves Ironwood Pharma's gout drug,2017-08-21 13:18:36 +0000,https://finance.yahoo.com/news/fda-approves-ironwood-pharmas-gout-131836450.html?.tsrc=rss,"Ironwood Pharmaceuticals Inc  said on Monday the U.S. Food and Drug Administration (FDA)  approved its oral drug to treat a condition associated with  gout.  The company's once-daily drug, Duzallo, was approved to  treat hyperuricemia — a condition characterized by too much uric  acid in blood — in patients with gout, Ironwood said.  Duzallo combines the standard of care treatment,  allopurinol, with Ironwood's lesinurad to treat inefficient  excretion and overproduction of uric acid in gout patients."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO® (lesinurad and allopurinol) for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout,2017-08-21 12:00:00 +0000,https://finance.yahoo.com/news/ironwood-pharmaceuticals-announces-fda-approval-120000785.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. today announced DUZALLO was approved by the U.S. Food and Drug Administration as a once-daily oral treatment for hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a medically appropriate daily dose of allopurinol alone."
IRWD,IRWD:UW,BBG000GBZJP0,See what the IHS Markit Score report has to say about Ironwood Pharmaceuticals Inc.,2017-08-16 12:03:25 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120325224.html?.tsrc=rss,Ironwood Pharmaceuticals Inc NASDAQ/NGS:IRWD
IRWD,IRWD:UW,BBG000GBZJP0,Edited Transcript of IRWD earnings conference call or presentation 3-Aug-17 8:30pm GMT,2017-08-13 15:15:52 +0000,https://finance.yahoo.com/news/edited-transcript-irwd-earnings-conference-051658866.html?.tsrc=rss,Q2 2017 Ironwood Pharmaceuticals Inc Earnings Call
IRWD,IRWD:UW,BBG000GBZJP0,See what the IHS Markit Score report has to say about Ironwood Pharmaceuticals Inc.,2017-08-12 12:02:40 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120240008.html?.tsrc=rss,"Short interest is moderately high for IRWD with between 10 and 15% of shares outstanding currently on loan.  This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on July 27.  Over the last one-month, outflows of investor capital in ETFs holding IRWD totaled $507 million."
IRWD,IRWD:UW,BBG000GBZJP0,See what the IHS Markit Score report has to say about Ironwood Pharmaceuticals Inc.,2017-08-11 12:03:48 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120348574.html?.tsrc=rss,"Short interest is moderately high for IRWD with between 10 and 15% of shares outstanding currently on loan.  This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on July 27.  Over the last one-month, outflows of investor capital in ETFs holding IRWD totaled $507 million."
IRWD,IRWD:UW,BBG000GBZJP0,Here's Why Synergy Pharmaceuticals Inc. Is Falling Today,2017-08-10 16:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bcqjUOSw7Wc/heres-why-synergy-pharmaceuticals-inc-is-falling-today-cm830301,What happened After posting a much higher loss than Wall Street expected shares of Synergy Pharmaceuticals NASDAQ SGYP a commercial stage biopharma focused on diseases of the gastrointestinal system fell as much as 13 in early morning trading on Thursday before they started
IRWD,IRWD:UW,BBG000GBZJP0,Synergy Pharmaceuticals Inc. Tanked 14.2% in July -- but Why?,2017-08-08 20:37:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T0buUMNrdkI/synergy-pharmaceuticals-inc-tanked-142-in-july-but-why-cm829006,What happened Synergy Pharmaceuticals NASDAQ SGYP a commercial stage biopharma focused on gastrointestinal diseases fell more than 14 in July according to data from S amp P Global Market Intelligence However there wasn t any news released during the month that
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood (IRWD) Q2 Loss Widens, Revenues Miss, Stock Up",2017-08-04 16:03:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yZKQWNaHvdw/ironwood-irwd-q2-loss-widens-revenues-miss-stock-up-cm827222,Ironwood Pharmaceuticals Inc IRWD reported second quarter 2017 adjusted loss of 28 cents per share wider than both the Zacks Consensus Estimate of a loss of 23 cents and the year ago loss of 16 cents Total revenue collaborative revenue in the quarter amounted to 65 1 million up 19
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood (IRWD) Q2 Loss Widens, Revenues Miss, Stock Up",2017-08-04 14:20:02 +0000,https://finance.yahoo.com/news/ironwood-irwd-q2-loss-widens-142002948.html?.tsrc=rss,"Ironwood Pharmaceuticals&apos; (IRWD) second-quarter results were dismal, missing sales and earnings estimates."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood reports 2Q loss,2017-08-04 04:07:45 +0000,https://finance.yahoo.com/news/ironwood-reports-2q-loss-221333248.html?.tsrc=rss,"The Cambridge, Massachusetts-based company said it had a loss of 30 cents per share. Losses, adjusted for non-recurring costs and amortization costs, were 28 cents per share. The results fell short of ..."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : August 4, 2017",2017-08-04 02:44:51 +0000,http://finance.yahoo.com/r/f5266c31-55a7-3295-a046-6d8be3401bb1/ironwood-pharmaceuticals-inc-value-analysis-nasdaqirwd-august-4-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Ironwood Pharmaceuticals, Inc. a score of 47. Our analysis is based on comparing Ironwood Pharmaceuticals, Inc. with the following peers – Progenics Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. (PGNX-US, SGYP-US, ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : August 4, 2017",2017-08-04 00:31:30 +0000,http://finance.yahoo.com/r/7102c968-a955-3371-a1fd-7ab44ef67f68/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-august-4-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Provides Second Quarter 2017 Investor Update,2017-08-03 20:01:00 +0000,https://finance.yahoo.com/news/ironwood-pharmaceuticals-provides-second-quarter-200100295.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, today provided an update on its second quarter 2017 results and recent business activities."
IRWD,IRWD:UW,BBG000GBZJP0,"Investor Network: Ironwood Pharmaceuticals, Inc. to Host Earnings Call",2017-08-03 15:40:00 +0000,https://finance.yahoo.com/news/investor-network-ironwood-pharmaceuticals-inc-154000188.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 3, 2017 / Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 3, 2017 at ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood (IRWD) Reports Positive Data on Reflux Candidate,2017-07-21 18:06:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qbbIVgqvd8E/ironwood-irwd-reports-positive-data-on-reflux-candidate-cm819469,Ironwood Pharmaceuticals Inc IRWD announced positive top line data from a phase IIb study evaluating its gastrointestinal GI candidate IW 3718 for the treatment of uncontrolled gastroesophageal reflux disease GERD in adult patients The study met its primary endpoint The
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood (IRWD) Reports Positive Data on Reflux Candidate,2017-07-21 15:56:03 +0000,https://finance.yahoo.com/news/ironwood-irwd-reports-positive-data-155603795.html?.tsrc=rss,Ironwood&apos;s GI candidate met the primary endpoint of a phase IIb study. It showed significant reduction in weekly heartburn severity in adult patients with reflux disease.
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood's Pipeline Needs Work, Analyst Downgrades",2017-07-21 14:47:44 +0000,https://finance.yahoo.com/news/ironwoods-pipeline-needs-analyst-downgrades-144744296.html?.tsrc=rss,"Analysts at JPMorgan no longer hold a bullish view on Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) after the company released top-line results from a phase 2b trial called IW-3718. The firm's Anupam ..."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : July 21, 2017",2017-07-21 13:25:25 +0000,http://finance.yahoo.com/r/ff2f8989-94de-3973-8b64-fbd2d59cf682/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-irwd-us-july-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Ironwood Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,"Gainers & Losers Of July 20: SRPT, AKCA, AGRX, INO, IRWD...",2017-07-20 21:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Eir5vxzbdyA/gainers--losers-of-july-20-srpt-akca-agrx-ino-irwd-20170720-01748,"Gainers & Losers Of July 20: SRPT, AKCA, AGRX, INO, IRWD..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Host Second Quarter 2017 Investor Update Call,2017-07-20 20:01:00 +0000,https://finance.yahoo.com/news/ironwood-pharmaceuticals-host-second-quarter-200100291.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. today announced it will host its second quarter 2017 investor update conference call and webcast at 4:30 p.m. Eastern Time on Thursday, August 3, 2017."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood reflux drug appears effective, safe in midstage trial",2017-07-20 12:00:01 +0000,https://finance.yahoo.com/news/ironwood-reflux-drug-appears-effective-120001413.html?.tsrc=rss,"Ironwood Pharmaceuticals Inc  said on Thursday its potential blockbuster drug for  gastroesophageal reflux disease (GERD) not controlled by current  medicines significantly reduced heartburn severity and  regurgitation frequency, meeting the main goals of a midstage  trial.  In the eight-week, 282-patient trial the experimental drug,  IW-3718, was given on top of widely used drugs for the painful  condition, such as Prilosec or Nexium, and compared with those  taking just the standard treatments, known as proton pump  inhibitors (PPI)."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Reports Positive Top-line Results from IW-3718 Phase IIb Trial in Uncontrolled Gastroesophageal Reflux Disease,2017-07-20 12:00:00 +0000,https://finance.yahoo.com/news/ironwood-pharmaceuticals-reports-positive-top-120000252.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, announced positive top-line data from a Phase IIb clinical trial evaluating IW-3718 in adult patients with uncontrolled gastroesophageal reflux disease ."
IRWD,IRWD:UW,BBG000GBZJP0,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : July 13, 2017",2017-07-13 20:07:36 +0000,http://finance.yahoo.com/r/9a8366b0-6516-3dd0-bff8-22b784135b0c/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-july-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,Allergan Reports Positive New Data on Irritable Bowl Drug,2017-07-11 22:45:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nD2EhBsyE_8/allergan-reports-positive-new-data-on-irritable-bowl-drug-cm814761,Allergan plc AGN has announced encouraging results from a pooled analysis of two phase III studies evaluating the efficacy and safety of its marketed drug Viberzi eluxadoline for treatment of adults suffering from irritable bowel syndrome with diarrhea IBS D Notably the drug is
IRWD,IRWD:UW,BBG000GBZJP0,Today's Research Reports on Trending Tickers: Ironwood Pharmaceuticals and Under Armour,2017-07-03 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000282.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 3, 2017 / Despite the recent weakness from technology and health-care stocks, U.S. markets were able to post strong performances for the first half of 2017. The Dow Jones ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Reaches Analyst Target Price,2017-06-29 14:03:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PQrSD95p-t8/ironwood-pharmaceuticals-reaches-analyst-target-price-cm809838,In recent trading shares of Ironwood Pharmaceuticals Inc Symbol IRWD have crossed above the average analyst 12 month target price of 18 19 changing hands for 18 31 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on
IRWD,IRWD:UW,BBG000GBZJP0,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : June 26, 2017",2017-06-26 20:14:20 +0000,http://finance.yahoo.com/r/2cc1f530-b38f-3890-aea5-02e40af54d8e/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-june-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : June 16, 2017",2017-06-16 19:57:25 +0000,http://finance.yahoo.com/r/50e56715-4d44-32f0-a234-be9514f14cf6/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q1, 2017 By the Numbers : June 15, 2017",2017-06-15 13:46:20 +0000,http://finance.yahoo.com/r/5a6ddcb4-6fc9-314e-aedf-70d07e9dd9fd/ironwood-pharmaceuticals-inc-irwd-us-earnings-analysis-q1-2017-by-the-numbers-june-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Ironwood Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Ironwood Pharmaceuticals, Inc. – Progenics Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,Why Is Ironwood (IRWD) Up 6.9% Since the Last Earnings Report?,2017-06-12 10:26:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GgnGbkujrzQ/why-is-ironwood-irwd-up-69-since-the-last-earnings-report-cm801745,It has been about a month since the last earnings report for Ironwood Pharmaceuticals Inc IRWD Shares have added about 6 9 in that time frame outperforming the market Will the recent positive trend continue leading up to the stock s next earnings release or is it due for a
IRWD,IRWD:UW,BBG000GBZJP0,Why Is Ironwood (IRWD) Up 6.9% Since the Last Earnings Report?,2017-06-12 08:42:08 +0000,https://finance.yahoo.com/news/why-ironwood-irwd-6-9-084208219.html?.tsrc=rss,Ironwood (IRWD) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at the Goldman Sachs 38th Annual Global Healthcare Conference,2017-06-08 20:01:00 +0000,https://finance.yahoo.com/news/ironwood-pharmaceuticals-present-goldman-sachs-200100744.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. will present a corporate update at the Goldman Sachs 38th Annual Global Healthcare Conference on Thursday, June 15, 2017 at 10:00 a.m. Pacific Time (1:00 p.m."
IRWD,IRWD:UW,BBG000GBZJP0,Is Ironwood's Growth About to Slow?,2017-06-05 15:04:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/doAJjTW9OPc/is-ironwoods-growth-about-to-slow-cm798639,Ironwood Pharmaceuticals NASDAQ IRWD shares are nudging up against 52 week highs because of optimism surrounding Linzess a drug used in treating chronic idiopathic constipation CIC and irritable bowel syndrome associated with constipation IBS C Linzess sales have grown
IRWD,IRWD:UW,BBG000GBZJP0,Is Ironwood&apos;s Growth About to Slow?,2017-06-05 13:01:00 +0000,http://finance.yahoo.com/r/ecf14ce9-240a-3d38-8891-2124434fcdc3/is-ironwoods-growth-about-to-slow.aspx?yptr=yahoo&.tsrc=rss,New competition could slow prescription growth for Linzess and take some of the luster off this small-cap biotech stock.
IRWD,IRWD:UW,BBG000GBZJP0,Why Synergy Pharmaceuticals Shares Are Popping 16.7% Today,2017-06-02 18:32:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KLEESmcYUdI/why-synergy-pharmaceuticals-shares-are-popping-167-today-cm798140,What happened Synergy Pharmaceuticals NASDAQ SGYP 160 is rallying by 16 7 at 12 30 p m EDT after Cantor Fitzgerald initiated coverage with an overweight rating and a 11 price target this morning So what Cantor Fitzgerald s rating follows BTIG Research s
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at the Jefferies Healthcare Conference,2017-06-01 20:01:00 +0000,https://finance.yahoo.com/news/ironwood-pharmaceuticals-present-jefferies-healthcare-200100839.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. will present a corporate update at the Jefferies Healthcare Conference on Thursday, June 8, 2017 at 4:00 p.m. Eastern Time at the Grand Hyatt in New York City."
IRWD,IRWD:UW,BBG000GBZJP0,IRWD Crosses Above Average Analyst Target,2017-05-24 14:32:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5imf1tqXucY/irwd-crosses-above-average-analyst-target-cm793850,In recent trading shares of Ironwood Pharmaceuticals Inc Symbol IRWD have crossed above the average analyst 12 month target price of 18 19 changing hands for 18 31 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on
IRWD,IRWD:UW,BBG000GBZJP0,First Week of IRWD July 21st Options Trading,2017-05-23 16:16:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DUNas9gWufs/first-week-of-irwd-july-21st-options-trading-cm793337,Investors in Ironwood Pharmaceuticals Inc Symbol IRWD saw new options begin trading this week for the July 21st expiration At Stock Options Channel our YieldBoost formula has looked up and down the IRWD options chain for the new July 21st contracts and identified one put and one
IRWD,IRWD:UW,BBG000GBZJP0,"EcoR1 Capital, LLC Buys CytomX Therapeutics Inc, Cascadian Therapeutics Inc, Fate Therapeutics ...",2017-05-20 14:11:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GrQiKk_BhVs/ecor1-capital-llc-buys-cytomx-therapeutics-inc-cascadian-therapeutics-inc-fate-therapeutics-cm792267,EcoR1 Capital LLC New Purchases CTMX CASC FATE OVAS JNCE RGLS VSAR VIVE DRNA CCXI Added Positions ACRS LIFE ATRA ASND IRWD BMY Reduced Positions FGEN XNCR SNDX GLPG KIN Sold Out ALXN ARDX FPRX EDIT CMRX EGLT DERM CYTK BPMX
IRWD,IRWD:UW,BBG000GBZJP0,Allergan's Irritable Bowel Drug Viberzi Approved in Canada,2017-05-17 16:15:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/koJKe6prTjw/allergans-irritable-bowel-drug-viberzi-approved-in-canada-cm790612,Allergan plc AGN announced that Health Canada has approved Viberzi eluxadoline for the treatment of adults suffering with irritable bowel syndrome with diarrhea IBS D The drug is marketed in the U S and Europe as a twice daily oral treatment A look at the company s share price
IRWD,IRWD:UW,BBG000GBZJP0,Allergan&apos;s Irritable Bowel Drug Viberzi Approved in Canada,2017-05-17 14:01:02 +0000,https://finance.yahoo.com/news/allergan-apos-irritable-bowel-drug-140102069.html?.tsrc=rss,Allergan plc (AGN) announced that Health Canada approved Viberzi (eluxadoline) for the treatment of adults suffering with irritable bowel syndrome with diarrhea (IBS-D)
IRWD,IRWD:UW,BBG000GBZJP0,Edited Transcript of IRWD earnings conference call or presentation 8-May-17 12:30pm GMT,2017-05-12 23:16:07 +0000,https://finance.yahoo.com/news/edited-transcript-irwd-earnings-conference-194905238.html?.tsrc=rss,Q1 2017 Ironwood Pharmaceuticals Inc Earnings Call
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : May 11, 2017",2017-05-11 22:59:16 +0000,http://finance.yahoo.com/r/485b1f63-5bd7-3aec-9468-39e6e32a5a72/ironwood-pharmaceuticals-inc-value-analysis-nasdaqirwd-may-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Ironwood Pharmaceuticals, Inc. a score of 31. Our analysis is based on comparing Ironwood Pharmaceuticals, Inc. with the following peers – Progenics Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. (PGNX-US, SGYP-US, ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference,2017-05-10 20:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-bank-america-200100553.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. will present a corporate update at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 17, 2017 at 1:00 p.m. Pacific Time / 4:00 p.m."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : IRWD-US : May 10, 2017",2017-05-10 12:17:40 +0000,http://finance.yahoo.com/r/2d02a6dc-6989-3d2e-9e22-0113e554ab5f/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-irwd-us-may-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Ironwood Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Presents Data Further Elucidating Linaclotide’s Effect on Pain at Digestive Disease Week® 2017,2017-05-09 20:05:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-presents-data-further-200500472.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, this week presented clinical data on the effect of linaclotide on abdominal pain in irritable bowel syndrome with constipation patients and preclinical data on linaclotide’s effect on pain originating in other visceral organs at Digestive Disease Week® 2017 in Chicago."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood (IRWD) Q1 Loss Wider than Expected, Sales Miss",2017-05-09 16:06:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XwcOUXODK2w/ironwood-irwd-q1-loss-wider-than-expected-sales-miss-cm786547,Ironwood Pharmaceuticals Inc IRWD reported first quarter 2017 adjusted loss of 33 cents per share significantly wider than both the Zacks Consensus Estimate of a loss of 19 cents and the year ago loss of 8 cents Total revenue collaborative revenues in the quarter amounted to 52
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood (IRWD) Q1 Loss Wider than Expected, Sales Miss",2017-05-09 13:46:01 +0000,http://finance.yahoo.com/news/ironwood-irwd-q1-loss-wider-134601209.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. (IRWD) reported first-quarter 2017 adjusted loss of 33 cents per share, significantly wider than both the Zacks Consensus Estimate of a loss of 19 cents and the year-ago loss of 8 cents."
IRWD,IRWD:UW,BBG000GBZJP0,Edited Transcript of IRWD earnings conference call or presentation 8-May-17 12:30pm GMT,2017-05-09 01:05:59 +0000,http://finance.yahoo.com/news/edited-transcript-irwd-earnings-conference-194905238.html?.tsrc=rss,Q1 2017 Ironwood Pharmaceuticals Inc Earnings Call
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood reports 1Q loss,2017-05-08 12:18:21 +0000,http://finance.yahoo.com/news/ironwood-reports-1q-loss-121821330.html?.tsrc=rss,"The Cambridge, Massachusetts-based company said it had a loss of 36 cents per share. Losses, adjusted for non-recurring costs, came to 33 cents per share. The results missed Wall Street expectations. The ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Provides First Quarter 2017 Investor Update,2017-05-08 12:00:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-provides-first-quarter-120000284.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, today provided an update on its first quarter 2017 results and recent business activities."
IRWD,IRWD:UW,BBG000GBZJP0,"Investor Network: Ironwood Pharmaceuticals, Inc. to Host Earnings Call",2017-05-08 11:15:00 +0000,http://finance.yahoo.com/news/investor-network-ironwood-pharmaceuticals-inc-111500798.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 8, 2017 / Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) will be discussing their earnings results in their Q1 Earnings Call to be held May 8, 2017 at 8:30 AM Eastern Time. ..."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals to Present New Data for Linaclotide, Linaclotide Delayed Release and IW-1701 at Digestive Disease Week® 2017",2017-05-01 11:30:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-data-linaclotide-113000063.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, today announced that the company and its collaborators will present clinical and preclinical data for linaclotide and linaclotide delayed release, as well as preclinical data for IW-1701, during Digestive Disease Week in Chicago, May 6 through May 9, 2017."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Host First Quarter 2017 Investor Update Call,2017-04-24 20:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-host-first-quarter-200100598.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. today announced it will host its first quarter 2017 investor update conference call and webcast at 8:30 a.m. Eastern Time on Monday, May 8, 2017."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Becomes Oversold (IRWD),2017-04-18 17:03:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jun8sCGGcT8/ironwood-pharmaceuticals-becomes-oversold-irwd-cm775320,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
IRWD,IRWD:UW,BBG000GBZJP0,Are Options Traders Betting on a Big Move in Ironwood Pharmaceuticals (IRWD) Stock?,2017-04-18 15:08:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D-wDdmiNkRo/are-options-traders-betting-on-a-big-move-in-ironwood-pharmaceuticals-irwd-stock-cm775172,Investors in Ironwood Pharmaceuticals Inc IRWD need to pay close attention to the stock based on moves in the options market lately That is because the Apr 21 st 2017 20 Puthad some of the highest implied volatility of all equity options today What is Implied Volatility
IRWD,IRWD:UW,BBG000GBZJP0,Are Options Traders Betting on a Big Move in Ironwood Pharmaceuticals (IRWD) Stock?,2017-04-18 12:42:12 +0000,http://finance.yahoo.com/news/options-traders-betting-big-move-124212628.html?.tsrc=rss,Huge implied volatility makes Ironwood Pharmaceuticals (IRWD) Stock lucrative to the option traders.
IRWD,IRWD:UW,BBG000GBZJP0,Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5),2017-04-13 13:00:00 +0000,http://finance.yahoo.com/news/allergan-ironwood-launch-campaign-designed-130000496.html?.tsrc=rss,"DUBLIN and CAMBRIDGE, Mass., April 13, 2017 /PRNewswire/ -- Allergan plc (AGN) and Ironwood Pharmaceuticals Inc. (IRWD), in partnership with the American Gastroenterological Association (AGA), initiated a campaign about the importance of bowel health in recognition of Irritable Bowel Syndrome (IBS) Awareness Month, at the Vital Signs of Bowel Health Summit, which took place yesterday in New York City."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : April 6, 2017",2017-04-06 12:29:39 +0000,http://finance.yahoo.com/r/f4f714c5-ea43-3d67-8f83-092feb3459db/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-irwd-us-april-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Ironwood Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice President of Global Development and Chief Development Officer,2017-04-06 12:00:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-appoints-dr-christopher-120000332.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, today announced the appointment of Christopher Wright, M.D., MMSc., Ph.D., as senior vice president of global development and chief development officer."
IRWD,IRWD:UW,BBG000GBZJP0,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : April 5, 2017",2017-04-05 20:57:12 +0000,http://finance.yahoo.com/r/ad5ebfe4-4d5f-3664-aee5-67067886bf6f/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-april-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin",2017-03-30 20:12:16 +0000,http://biz.yahoo.com/e/170330/irwd8-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin"
IRWD,IRWD:UW,BBG000GBZJP0,First Week of November 17th Options Trading For Ironwood Pharmaceuticals (IRWD),2017-03-21 17:10:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FnZz59SFuy0/first-week-of-november-17th-options-trading-for-ironwood-pharmaceuticals-irwd-cm763620,Investors in Ironwood Pharmaceuticals Inc Symbol IRWD saw new options become available this week for the November 17th expiration One of the key inputs that goes into the price an option buyer is willing to pay is the time value so with 241 days until expiration the newly
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017",2017-03-17 15:31:51 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-irwd-us-earnings-analysis-q4-2016-by-the-numbers-march-17-2017/,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017",2017-03-17 15:31:51 +0000,http://finance.yahoo.com/r/46ccada7-2bf6-3250-8fe8-7aa809090ea5/ironwood-pharmaceuticals-inc-irwd-us-earnings-analysis-q4-2016-by-the-numbers-march-17-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Ironwood Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Ironwood Pharmaceuticals, Inc. – Progenics Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. (PGNX-US, NKTR-US, AZN-US, ... Read more    
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,IRWD Crosses Above Average Analyst Target,2017-03-15 15:07:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DqvDgdBBag0/irwd-crosses-above-average-analyst-target-cm761007,In recent trading shares of Ironwood Pharmaceuticals Inc Symbol IRWD have crossed above the average analyst 12 month target price of 17 12 changing hands for 17 16 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017",2017-03-14 18:35:58 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-irwd-us-earnings-analysis-2016-by-the-numbers-march-14-2017/,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017",2017-03-14 18:35:58 +0000,http://finance.yahoo.com/r/843daccc-b52c-302b-b00f-7a1948ca62a3/ironwood-pharmaceuticals-inc-irwd-us-earnings-analysis-2016-by-the-numbers-march-14-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Ironwood Pharmaceuticals, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Ironwood Pharmaceuticals, Inc. – Progenics Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. (PGNX-US, NKTR-US, AZN-US, ... Read more    
<b>(Read more...)</b>"
IRWD,IRWD:UW,BBG000GBZJP0,"Synergy Pharmaceuticals: Approval, Now What?",2017-03-13 14:08:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CCKVQ4IYkds/synergy-pharmaceuticals-approval-now-what-cm759912,Shares of Synergy Pharmaceuticals NASDAQ SGYP 160 are up more than 100 from their 2016 lows and the company finally received FDA approval of its drug Trulance plecanatide in January of this year However since the drug s approval the stock has traded down over 20 due to
IRWD,IRWD:UW,BBG000GBZJP0,"Synergy Pharmaceuticals: Approval, Now What?",2017-03-13 13:29:00 +0000,http://www.fool.com/investing/2017/03/13/synergy-pharmaceuticals-approval-now-what.aspx,"Synergy Pharmaceuticals: Approval, Now What?"
IRWD,IRWD:UW,BBG000GBZJP0,"Synergy Pharmaceuticals: Approval, Now What?",2017-03-13 13:29:00 +0000,http://finance.yahoo.com/r/6affd217-291f-3bc9-84ec-8cce63ebb462/synergy-pharmaceuticals-approval-now-what.aspx?yptr=yahoo&.tsrc=rss,Is Synergy a buy on the post-approval dip?
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference,2017-03-10 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-barclays-global-210100293.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. will present a corporate update at the Barclays Global Healthcare Conference on Thursday, March 16, 2017 at 10:45 a.m. Eastern Time at the Loews Miami Beach Hotel."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference,2017-03-10 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-barclays-global-210100293.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. will present a corporate update at the Barclays Global Healthcare Conference on Thursday, March 16, 2017 at 10:45 a.m. Eastern Time at the Loews Miami Beach Hotel."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Showcases Progress Delivering Innovative Medicines to Patients and Building a Top-Performing Commercial Biotech at R&D Day 2017,2017-03-09 13:30:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-showcases-progress-delivering-133000064.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, is hosting an R&D Day today, Thursday, March 9, 2017, beginning at 9:00 a.m. Eastern Time, at its headquarters in Cambridge, Mass."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Showcases Progress Delivering Innovative Medicines to Patients and Building a Top-Performing Commercial Biotech at R&D Day 2017,2017-03-09 13:30:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-showcases-progress-delivering-133000064.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, is hosting an R&D Day today, Thursday, March 9, 2017, beginning at 9:00 a.m. Eastern Time, at its headquarters in Cambridge, Mass."
IRWD,IRWD:UW,BBG000GBZJP0,[$$] Celebrating Failure in a Tough Drug Industry,2017-03-04 04:11:56 +0000,http://finance.yahoo.com/r/248f3873-227a-3c0f-8f17-7bb4247e0083/celebrating-failure-in-a-tough-drug-industry-1488568710?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Pharmaceutical companies are going to creative lengths to tackle a common problem: how to keep employees motivated despite a high rate of failed projects.
IRWD,IRWD:UW,BBG000GBZJP0,[$$] Celebrating Failure in a Tough Drug Industry,2017-03-04 04:11:56 +0000,https://www.wsj.com/articles/celebrating-failure-in-a-tough-drug-industry-1488568710?ru=yahoo?mod=yahoo_itp,[$$] Celebrating Failure in a Tough Drug Industry
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Cowen and Company 37th Annual Health Care Conference,2017-02-28 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-cowen-company-210100518.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. will present a corporate update at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017 at 2:00 p.m. Eastern Time at the Boston Marriott Copley Place."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Cowen and Company 37th Annual Health Care Conference,2017-02-28 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-cowen-company-210100518.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. will present a corporate update at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017 at 2:00 p.m. Eastern Time at the Boston Marriott Copley Place."
IRWD,IRWD:UW,BBG000GBZJP0,IRONWOOD PHARMACEUTICALS INC Financials,2017-02-28 18:04:11 +0000,http://finance.yahoo.com/q/is?s=irwd,IRONWOOD PHARMACEUTICALS INC Financials
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals to Host R&D Day on March 9, 2017",2017-02-23 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-host-r-d-210100926.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. will host a live webcast of its R&D Day on Thursday, March 9, 2017 beginning at 9:00 a.m. Eastern Time. Members of the Ironwood leadership team and external opinion leaders will provide R&D and commercial insights into key Ironwood product opportunities."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals to Host R&D Day on March 9, 2017",2017-02-23 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-host-r-d-210100926.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. will host a live webcast of its R&D Day on Thursday, March 9, 2017 beginning at 9:00 a.m. Eastern Time. Members of the Ironwood leadership team and external opinion leaders will provide R&D and commercial insights into key Ironwood product opportunities."
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 10-K, Annual Report",2017-02-22 22:14:46 +0000,http://biz.yahoo.com/e/170222/irwd10-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 10-K, Annual Report"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top,2017-02-22 17:52:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5gz4Ub_VeTU/ironwood-irwd-q4-loss-narrower-than-expected-sales-top-cm751417,Ironwood Pharmaceuticals Inc IRWD reported an adjusted loss of 12 cents per share in the fourth quarter of 2016 narrower than the Zacks Consensus Estimate of a loss of 23 cents but slightly wider than the year ago loss of 11 cents Total revenue collaborative revenues in the
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top,2017-02-22 15:34:03 +0000,http://finance.yahoo.com/news/ironwood-irwd-q4-loss-narrower-153403228.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. (IRWD) reported an adjusted loss of 12 cents per share in the fourth quarter of 2016, narrower than the Zacks Consensus Estimate of a loss of 23 cents but slightly wider than the year-ago loss of 11 cents."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top,2017-02-22 15:34:03 +0000,http://finance.yahoo.com/news/ironwood-irwd-q4-loss-narrower-153403228.html,Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood reports 4Q loss,2017-02-21 21:18:59 +0000,http://sg.finance.yahoo.com/news/ironwood-reports-4q-loss-211859642.html,Ironwood reports 4Q loss
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood reports 4Q loss,2017-02-21 21:18:59 +0000,http://finance.yahoo.com/news/ironwood-reports-4q-loss-211859063.html?.tsrc=rss,"On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 9 cents. Losses, adjusted for amortization gains and non-recurring gains, were 12 cents per share. The results exceeded ..."
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements",2017-02-21 21:12:17 +0000,http://biz.yahoo.com/e/170221/irwd8-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements"
IRWD,IRWD:UW,BBG000GBZJP0,"4:03 pm Ironwood Pharma beats by $0.10, beats on revs",2017-02-21 21:03:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#irwd,"4:03 pm Ironwood Pharma beats by $0.10, beats on revs"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update,2017-02-21 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-provides-fourth-quarter-210100188.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, today provided an update on its fourth quarter and full year 2016 results and recent business activities."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update,2017-02-21 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-provides-fourth-quarter-210100188.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, today provided an update on its fourth quarter and full year 2016 results and recent business activities."
IRWD,IRWD:UW,BBG000GBZJP0,Q4 2016 Ironwood Pharmaceuticals Inc Earnings Release - After Market Close,2017-02-21 12:07:06 +0000,http://biz.yahoo.com/research/earncal/20170221.html?t=irwd,Q4 2016 Ironwood Pharmaceuticals Inc Earnings Release - After Market Close
IRWD,IRWD:UW,BBG000GBZJP0,"Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS",2017-02-20 13:52:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HZDGy-X13Nw/drug-stocks-q4-earnings-lineup-for-feb-21-irwd-mnta-exas-cm750167,As the Q4 earnings season enters the last leg we believe this quarter is on track to witness the highest growth momentum in the last two years As of Feb 17 2017 411 S amp P 500 members accounting for 88 4 of the index s total market capitalization have reported results according to
IRWD,IRWD:UW,BBG000GBZJP0,"Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS",2017-02-20 11:52:11 +0000,http://finance.yahoo.com/news/drug-stocks-q4-earnings-lineup-115211830.html,"Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS"
IRWD,IRWD:UW,BBG000GBZJP0,"Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS",2017-02-20 11:52:11 +0000,http://finance.yahoo.com/news/drug-stocks-q4-earnings-lineup-115211830.html?.tsrc=rss,Here we have three pharma companies that are set to report fourth-quarter results on Feb 21. Let's see how things are shaping up for this quarter.
IRWD,IRWD:UW,BBG000GBZJP0,Radius Health (RDUS) Q4 Earnings: Will the Stock Disappoint?,2017-02-17 21:52:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4dUCIFDSRIE/radius-health-rdus-q4-earnings-will-the-stock-disappoint-cm749839,Radius Health Inc RDUS is scheduled to report fourth quarter 2016 financial results on Feb 23 Radius shares have underperformed the Medical Drugs industry in the last three months The stock lost 14 7 during this time period as compared to a gain of 4 4 for the industry
IRWD,IRWD:UW,BBG000GBZJP0,Radius Health (RDUS) Q4 Earnings: Will the Stock Disappoint?,2017-02-17 19:30:07 +0000,http://finance.yahoo.com/news/radius-health-rdus-q4-earnings-193007590.html,Radius Health (RDUS) Q4 Earnings: Will the Stock Disappoint?
IRWD,IRWD:UW,BBG000GBZJP0,5 Drug Stocks Poised to Beat Earnings Estimates in Q4,2017-02-09 14:20:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R733SkOwjzs/5-drug-stocks-poised-to-beat-earnings-estimates-in-q4-cm745419,A positive earnings picture continues to emerge from the fourth quarter earnings season with both earnings and revenue growth improving compared to recent quarters As of Feb 8 319 S amp P 500 members or 76 3 of the index s total market capitalization had reported results the numbers show
IRWD,IRWD:UW,BBG000GBZJP0,5 Drug Stocks Poised to Beat Earnings Estimates in Q4,2017-02-09 12:39:12 +0000,http://finance.yahoo.com/news/5-drug-stocks-poised-beat-123912751.html,5 Drug Stocks Poised to Beat Earnings Estimates in Q4
IRWD,IRWD:UW,BBG000GBZJP0,5 Drug Stocks Poised to Beat Earnings Estimates in Q4,2017-02-09 12:39:12 +0000,http://finance.yahoo.com/news/5-drug-stocks-poised-beat-123912751.html?.tsrc=rss,Medical is one of the few sectors that has consistently recorded earnings growth over the last 4 quarters. Here is a look at 5 pharma and biotech stocks that look set to beat Q4 earnings estimates.
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2016 Investor Update Call,2017-02-07 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-host-fourth-quarter-210100783.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. today announced it will host its fourth quarter and full-year 2016 investor update conference call and webcast at 4:30 p.m. Eastern Time on Tuesday, February 21, 2017."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2016 Investor Update Call,2017-02-07 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-host-fourth-quarter-210100783.html?.tsrc=rss,"Ironwood Pharmaceuticals, Inc. today announced it will host its fourth quarter and full-year 2016 investor update conference call and webcast at 4:30 p.m. Eastern Time on Tuesday, February 21, 2017."
IRWD,IRWD:UW,BBG000GBZJP0,Why Synergy Pharmaceuticals Shares Fell 14.6% Today,2017-02-02 00:31:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hfE61LYRJJ4/why-synergy-pharmaceuticals-shares-fell-146-today-cm741916,IMAGE SOURCE GETTY IMAGES What happened Synergy Pharmaceuticals NASDAQ SGYP 160 announced a 125 million stock offering yesterday and shares slipped 14 6 today after the company announced it s pricing the offering at 6 15 per share So what
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement",2017-02-01 22:02:35 +0000,http://biz.yahoo.com/e/170201/irwd8-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood/Astellas Report Positive Phase III Data on Linzess,2017-01-30 14:35:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RuwpfeswvHQ/ironwoodastellas-report-positive-phase-iii-data-on-linzess-cm739983,Ironwood Pharmaceuticals Inc IRWD and partner Astellas Pharma Inc reported positive top line data from a phase III study on Linzess EU trade name Constella in adults with chronic constipation CC A look at Ironwood s share price movement over the past one year shows that the
IRWD,IRWD:UW,BBG000GBZJP0,"Premarket Biotech Movers: Ironwood Pharmaceuticals, Rigel Pharmaceuticals, FibroGen",2017-01-30 14:21:00 +0000,https://www.thestreet.com/story/13970890/1/premarket-biotech-movers-ironwood-pharmaceuticals-rigel-pharmaceuticals-fibrogen.html?puc=yahoo&cm_ven=YAHOO,"Premarket Biotech Movers: Ironwood Pharmaceuticals, Rigel Pharmaceuticals, FibroGen"
IRWD,IRWD:UW,BBG000GBZJP0,"Premarket Biotech Movers: Ironwood Pharmaceuticals, Rigel Pharmaceuticals, FibroGen",2017-01-30 14:21:00 +0000,http://finance.yahoo.com/r/2d8f11c4-7079-3fb8-9177-c922a0c779fb/premarket-biotech-movers-ironwood-pharmaceuticals-rigel-pharmaceuticals-fibrogen.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Ironwood Pharmaceuticals, Rigel Pharmaceuticals and FibroGen were among the biotech stock movers in premarket trading on Monday."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood/Astellas Report Positive Phase III Data on Linzess,2017-01-30 12:35:12 +0000,http://finance.yahoo.com/news/ironwood-astellas-report-positive-phase-123512150.html,Ironwood/Astellas Report Positive Phase III Data on Linzess
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood/Astellas Report Positive Phase III Data on Linzess,2017-01-30 12:35:12 +0000,http://finance.yahoo.com/news/ironwood-astellas-report-positive-phase-123512150.html?.tsrc=rss,Ironwood (IRWD) and partner Astellas reported positive top-line data from a phase III study on Linzess in adults with chronic constipation.
IRWD,IRWD:UW,BBG000GBZJP0,Astellas and Ironwood Report Positive Top-Line Results from Phase III Linaclotide Trial for Patients with Chronic Constipation Conducted in Japan,2017-01-30 00:00:00 +0000,http://au.finance.yahoo.com/news/astellas-ironwood-report-positive-top-000000233.html,"[Business Wire] - TOKYO & CAMBRIDGE, Mass.--(BUSINESSWIRE)-- Astellas Pharma Inc. (TSE:4503) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - News) announced today top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation (CC) met its primary endpoint. Linaclotide is approved in Japan as the first prescription treatment for adults with irritable bowel syndrome with constipation (IBS-C)."
IRWD,IRWD:UW,BBG000GBZJP0,Astellas And Ironwood Report Positive Results From Phase III Linaclotide Trial,2017-01-29 19:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F4LzcZQhLZc/astellas-and-ironwood-report-positive-results-from-phase-iii-linaclotide-trial-20170129-00032,Astellas And Ironwood Report Positive Results From Phase III Linaclotide Trial
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood-Allergan Linzess Gets FDA Approval in Lower Dose,2017-01-27 16:36:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K3EBVP1WRgM/ironwood-allergan-linzess-gets-fda-approval-in-lower-dose-cm739395,Ironwood Pharmaceuticals Inc IRWD and partner Allergan plc AGN announced that the FDA has approved a lower dose strength of Linzess linaclotide 72 mcg for the treatment of adult patients with chronic idiopathic constipation CIC The lower dose is expected to be available in the U
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood-Allergan Linzess Gets FDA Approval in Lower Dose,2017-01-27 14:19:02 +0000,http://finance.yahoo.com/news/ironwood-allergan-linzess-gets-fda-141902446.html,Ironwood-Allergan Linzess Gets FDA Approval in Lower Dose
IRWD,IRWD:UW,BBG000GBZJP0,U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (linaclotide) for Adults with Chronic Idiopathic Constipation,2017-01-26 12:01:00 +0000,http://finance.yahoo.com/news/u-food-drug-administration-approves-120100169.html,"[PR Newswire] - CAMBRIDGE, Mass. and DUBLIN, Jan. 26, 2017 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. (IRWD) and Allergan plc (AGN) announced today that the U.S. Food and Drug Administration (FDA) has approved a 72 mcg dose of LINZESS® (linaclotide) for the treatment of chronic idiopathic constipation (CIC) in adult patients. The newly approved dose will provide physicians with dosing flexibility based on individual presentation or tolerability, in treating the large and heterogenous population of adult CIC patients. LINZESS is now FDA-approved in three dosage strengths: 290 mcg for adult patients with irritable bowel syndrome with constipation (IBS-C), and 145 mcg and a new 72 mcg for the treatment of adults with CIC."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood, Allergan: FDA Approves 72mcg Dose Of Linzess For Adult CIC Patients",2017-01-26 08:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H5gyNoqcC-Y/ironwood-allergan-fda-approves-72mcg-dose-of-linzess-for-adult-cic-patients-20170126-00653,"Ironwood, Allergan: FDA Approves 72mcg Dose Of Linzess For Adult CIC Patients"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. (IRWD) Has A Near Term Catalyst To Watch",2017-01-24 17:27:11 +0000,http://www.insidermonkey.com/blog/ironwood-pharmaceuticals-inc-irwd-has-a-near-term-catalyst-to-watch-523214/,"Ironwood Pharmaceuticals, Inc. (IRWD) Has A Near Term Catalyst To Watch"
IRWD,IRWD:UW,BBG000GBZJP0,UPDATE 1-Synergy wins U.S. approval for constipation drug (Jan 19),2017-01-24 16:23:19 +0000,http://finance.yahoo.com/news/1-synergy-wins-u-approval-162319240.html,"[Reuters] - The U.S. Food and Drug Administration said on Thursday it had approved Synergy Pharmaceuticals Inc's drug to treat chronic idiopathic constipation (CIC). CIC, which affects 14 percent of the global population, is a type of gastrointestinal disorder where individuals have difficult and infrequent bowel movements. Trulance met the main goals of two late-stage studies in December on irritable bowel syndrome patients with constipation (IBS-C)."
IRWD,IRWD:UW,BBG000GBZJP0,Synergy Pharmaceuticals Secures Approval for Linzess Competitor,2017-01-20 15:37:00 +0000,https://www.thestreet.com/story/13960531/1/synergy-pharmaceuticals-secures-approval-for-linzess-competitor.html?puc=yahoo&cm_ven=YAHOO,Synergy Pharmaceuticals Secures Approval for Linzess Competitor
IRWD,IRWD:UW,BBG000GBZJP0,FDA OKs Synergy Pharmaceuticals Constipation Drug,2017-01-20 14:37:00 +0000,http://www.investopedia.com/news/synergy-constipation-drug-gets-fda-approval-sgyp/?partner=YahooSA,FDA OKs Synergy Pharmaceuticals Constipation Drug
IRWD,IRWD:UW,BBG000GBZJP0,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : January 17, 2017",2017-01-17 17:16:01 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-january-17-2017/,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : January 17, 2017"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : IRWD-US : January 16, 2017",2017-01-16 12:42:27 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-irwd-us-january-16-2017/,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : IRWD-US : January 16, 2017"
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements",2017-01-09 12:02:55 +0000,http://biz.yahoo.com/e/170109/irwd8-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Demonstrates Strong Execution on Strategy to Build Top-Performing Commercial Biotech,2017-01-09 01:00:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-demonstrates-strong-execution-010000654.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. today detailed strong execution against its strategy of building a top-performing commercial biotechnology company generating rapid, sustainable, high-margin growth."
IRWD,IRWD:UW,BBG000GBZJP0,Post Earnings Coverage as Patheon's Q4 Revenue Beat Market Estimates,2017-01-06 13:15:00 +0000,http://finance.yahoo.com/news/post-earnings-coverage-patheons-q4-131500953.html,"[Accesswire] - Upcoming AWS Coverage on Ironwood Pharmaceuticals LONDON, UK / ACCESSWIRE / January 6, 2017 / Active Wall St. announces its post-earnings coverage on Patheon Holdings Cooperatief U.A. (NASDAQ: PTHN ). ..."
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement",2017-01-05 21:07:00 +0000,http://biz.yahoo.com/e/170105/irwd8-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement"
IRWD,IRWD:UW,BBG000GBZJP0,A David and Goliath Story: Can Small-Cap Synergy Pharmaceuticals Take on Ironwood Pharmaceuticals?,2017-01-05 17:40:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BQlz3jO8yIg/a-david-and-goliath-story-can-small-cap-synergy-pharmaceuticals-take-on-ironwood-pharmaceuticals-cm729945,Image source Pixabay The past few months have been good to investors in competing companies Ironwood Pharmaceuticals NASDAQ IRWD and Synergy Pharmaceuticals NASDAQ SGYP with shares of both companies up by double digits SGYP data
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : January 5, 2017",2017-01-05 16:17:10 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-value-analysis-nasdaqirwd-january-5-2017/,"Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : January 5, 2017"
IRWD,IRWD:UW,BBG000GBZJP0,A David and Goliath Story: Can Small-Cap Synergy Pharmaceuticals Take on Ironwood Pharmaceuticals?,2017-01-05 15:55:22 +0000,http://www.fool.com/investing/2017/01/05/a-david-and-goliath-story-can-small-cap-synergy-ph.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,A David and Goliath Story: Can Small-Cap Synergy Pharmaceuticals Take on Ironwood Pharmaceuticals?
IRWD,IRWD:UW,BBG000GBZJP0,"AEZS Disappoints, EVOK Gets New Lease Of Life, GNMX Calls For Attention",2017-01-05 00:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/47JUs3PW9eI/aezs-disappoints-evok-gets-new-lease-of-life-gnmx-calls-for-attention-20170105-00006,"AEZS Disappoints, EVOK Gets New Lease Of Life, GNMX Calls For Attention"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Appoints Amy Schulman to Board of Directors,2017-01-04 21:33:12 +0000,http://www.publicnow.com/view/8853579BFBC14B05E4253990EB4D3EA4EB070F9D,"[at noodls] - January 4, 2017 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) today announced the appointment of Amy Schulman to its board of directors. Schulman is an accomplished leader ..."
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and",2017-01-04 21:12:55 +0000,http://biz.yahoo.com/e/170104/irwd8-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : January 4, 2017",2017-01-04 14:01:24 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-irwd-us-january-4-2017/,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : January 4, 2017"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Announces New Drug Application for DUZALLO™ (Fixed-Dose Combination of Lesinurad and Allopurinol) Has Been Accepted for FDA Review,2017-01-04 13:33:20 +0000,http://www.publicnow.com/view/4A54E8110DBDF68A63CA58DEDD51CEBF8AEFE8CE,"[at noodls] - January 4, 2017 If approved, DUZALLO would be first dual-mechanism treatment for patients with uncontrolled gout CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Announces New Drug Application for DUZALLO™ (Fixed-Dose Combination of Lesinurad and Allopurinol) Has Been Accepted for FDA Review,2017-01-04 13:00:00 +0000,http://finance.yahoo.com/news/ironwood-announces-drug-application-duzallo-130000276.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration accepted for review a New Drug Application for DUZALLO™ for the treatment of hyperuricemia in patients with uncontrolled gout."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference,2017-01-03 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-j-p-210100056.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. will present a corporate update at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 12:00 p.m. Pacific Time / 3:00 p.m."
IRWD,IRWD:UW,BBG000GBZJP0,Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse,2016-12-23 21:04:28 +0000,http://www.investors.com/news/technology/allergan-outlook-improves-on-good-trial-for-colon-drug-credit-suisse/,Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse
IRWD,IRWD:UW,BBG000GBZJP0,Why Synergy Pharmaceuticals Is Jumping 10% Today,2016-12-23 17:57:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OCGdRp-ekB4/why-synergy-pharmaceuticals-is-jumping-10-today-cm725780,IMAGE SOURCE GETTY IMAGES What happened After announcing 160 positive results in phase 3 trials evaluating 160 plecanatide for the treatment of irritable bowel syndrome with constipation IBS C shares in Synergy Pharmaceuticals NASDAQ SGYP 160 rallied 10
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood, Allergan Report Positive Linzess IBS-C Study Data",2016-12-23 16:01:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uemYRp_wn8k/ironwood-allergan-report-positive-linzess-ibs-c-study-data-cm725670,Ironwood Pharmaceuticals Inc IRWD and Allergan plc AGN announced encouraging top line data from a phase IIb study on the colonic release 1 CR1 formulation of Linzess linaclotide for the treatment of adult patients suffering from irritable bowel syndrome with constipation IBS C In
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood, Allergan Report Positive Linzess IBS-C Study Data",2016-12-23 13:35:01 +0000,http://finance.yahoo.com/news/ironwood-allergan-report-positive-linzess-133501794.html,"Ironwood, Allergan Report Positive Linzess IBS-C Study Data"
IRWD,IRWD:UW,BBG000GBZJP0,Cambridge's Ironwood reports positive data on constipation drug,2016-12-22 16:20:09 +0000,http://www.bizjournals.com/boston/news/2016/12/22/cambridges-ironwood-reports-positive-data-on.html?ana=yahoo,Cambridge's Ironwood reports positive data on constipation drug
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Shares Eye 3.5-Yr High; Joint Trial With Allergan Shows Reduced Abdominal Pain,2016-12-22 12:57:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8nInu_T6VY0/ironwood-shares-eye-35-yr-high-joint-trial-with-allergan-shows-reduced-abdominal-pain-cm724938,Ironwood Pharmaceuticals IRWD shares were higher over 6 in recent pre market trade as it and Allergan AGN said a phase 2b clinical trial showed irritable bowel syndrome patients treated with its linaclotide colonic release 1 300 mcg saw a 56 2 improvement in abdominal pain relative
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood and Allergan Report Topline Phase IIb Data Supporting Advancement of Linaclotide Colonic Release-1 (CR1) in IBS-C,2016-12-22 12:52:17 +0000,http://www.publicnow.com/view/4D7AFCEF9C24EDE266C25B440DC3B8DB56A6FD4A,"[at noodls] - December 22, 2016 Abdominal pain improved 56% with CR1 300 mcg relative to placebo in this trial Companies separately announced Phase IIb data with linaclotide colonic release-2 (CR2) supporting investigation ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood and Allergan Report Topline Phase IIb Data Supporting Further Investigation of Linaclotide Colonic Release-2 (CR2) for Abdominal Pain in Non-Constipation Subtypes of IBS,2016-12-22 12:52:17 +0000,http://www.publicnow.com/view/BAB42BECBE6732751D74E1299D0AAB33A4DD8424,"[at noodls] - December 22, 2016 Data also support potential for broad opportunity to treat additional GI indications associated with abdominal pain Companies separately announced Phase IIb data with linaclotide colonic ..."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR-1 In IBS-C",2016-12-22 07:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OeqqyC9ZBqA/ironwood-allergan-report-topline-phase-iib-data-for-linaclotide-cr1-in-ibsc-20161222-00161,"Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR-1 In IBS-C"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR2",2016-12-22 07:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yy-7qdBp5Qs/ironwood-allergan-report-topline-phase-iib-data-for-linaclotide-cr2-20161222-00158,"Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR2"
IRWD,IRWD:UW,BBG000GBZJP0,"Small-cap fund produces big profits, even if some of its holdings don’t",2016-12-20 13:03:24 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F3F6A9E0-C3B1-11E6-A9C9-F723B10545EE&siteid=yhoof2,"Small-cap fund produces big profits, even if some of its holdings don’t"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Announces Approval of LINZESS® (linaclotide) in Japan for the Treatment of Adults with IBS-C,2016-12-19 11:41:13 +0000,http://www.publicnow.com/view/529F42CFFB2A573376E23B022B4FA2B0AB050170,"[at noodls] - December 19, 2016 -Approval Triggers $15 Million Milestone Payment to Ironwood from Astellas- CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) today announced that its partner, ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Announces Approval of LINZESS® (linaclotide) in Japan for the Treatment of Adults with IBS-C,2016-12-19 11:00:00 +0000,http://au.finance.yahoo.com/news/ironwood-pharmaceuticals-announces-approval-linzess-110000653.html,"[Business Wire] - CAMBRIDGE, Mass.--(BUSINESSWIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - News) today announced that its partner, Astellas Pharma Inc., secured marketing approval from the Japanese Ministry of Health, Labor and Welfare for LINZESS as the first prescription treatment for adults with irritable bowel syndrome with constipation (IBS-C) in Japan. Ironwood anticipates that Astellas will launch the drug in the first half of 2017. Linaclotide is a guanylate cyclase‐C (GC‐C) receptor agonist currently approved and available for the treatment of adults with IBS-C or chronic idiopathic constipation (CIC) in the United States and more than 30 other countries."
IRWD,IRWD:UW,BBG000GBZJP0,Is Kite Realty Group Trust (KRG) A Good Stock To Buy?,2016-12-12 22:35:28 +0000,http://www.insidermonkey.com/blog/is-kite-realty-group-trust-krg-a-good-stock-to-buy-506573/,Is Kite Realty Group Trust (KRG) A Good Stock To Buy?
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : December 8, 2016",2016-12-08 12:48:18 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-irwd-us-december-8-2016/,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : December 8, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,Is Controladora Vuela Co Avcn SA CV (ADR) (VLRS) Going to Burn These Hedge Funds?,2016-12-05 23:16:26 +0000,http://www.insidermonkey.com/blog/is-controladora-vuela-co-avcn-sa-cv-adr-vlrs-going-to-burn-these-hedge-funds-499154/,Is Controladora Vuela Co Avcn SA CV (ADR) (VLRS) Going to Burn These Hedge Funds?
IRWD,IRWD:UW,BBG000GBZJP0,"Hedge Funds Are Buying Ironwood Pharmaceuticals, Inc. (IRWD)",2016-11-29 23:53:16 +0000,http://www.insidermonkey.com/blog/hedge-funds-are-buying-ironwood-pharmaceuticals-inc-irwd-2-494761/,"Hedge Funds Are Buying Ironwood Pharmaceuticals, Inc. (IRWD)"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood (IRWD) Presents Positive Phase III Data on Zurampic,2016-11-15 14:30:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MqaVgPqZEI8/ironwood-irwd-presents-positive-phase-iii-data-on-zurampic-cm709360,Ironwood Pharmaceuticals Inc IRWD presented efficacy and safety data from two phase III extension studies on its marketed drug Zurampic lesinurad at the American College of Rheumatology ACR Annual Meeting in Washington D C The company also presented pooled analysis of the
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood (IRWD) Presents Positive Phase III Data on Zurampic,2016-11-15 12:52:12 +0000,http://finance.yahoo.com/news/ironwood-irwd-presents-positive-phase-125212220.html,Ironwood (IRWD) Presents Positive Phase III Data on Zurampic
IRWD,IRWD:UW,BBG000GBZJP0,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : November 14, 2016",2016-11-14 18:42:00 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-november-14-2016/,"ETFs with exposure to Ironwood Pharmaceuticals, Inc. : November 14, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Highlights ZURAMPIC® (lesinurad) Phase III Extension Study Data at the American College of Rheumatology 2016 Annual Meeting,2016-11-13 13:00:00 +0000,http://finance.yahoo.com/news/ironwood-highlights-zurampic-lesinurad-phase-130000140.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. today presented efficacy and safety data from two Phase III extension studies of ZURAMPIC , as well as pooled analyses from the two extension studies and from the three pivotal Phase III ZURAMPIC clinical trials, in four poster presentations at the American College of Rheumatology Annual Meeting in Washington, D.C."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Stifel 2016 Healthcare Conference,2016-11-10 21:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-stifel-2016-210100013.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. will present a corporate update at the Stifel 2016 Healthcare Conference on Wednesday, November 16th, 2016 at 8:00 a.m. Eastern Time at The Lotte New York Palace Hotel."
IRWD,IRWD:UW,BBG000GBZJP0,IRWD Crosses Above Average Analyst Target,2016-11-10 15:55:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pzSTmj0FWjA/irwd-crosses-above-average-analyst-target-cm707169,In recent trading shares of Ironwood Pharmaceuticals Inc Symbol IRWD have crossed above the average analyst 12 month target price of 15 38 changing hands for 16 13 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016",2016-11-10 15:53:15 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-irwd-us-earnings-analysis-q3-2016-by-the-numbers-november-10-2016/,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : IRWD-US : November 9, 2016",2016-11-09 12:27:02 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-irwd-us-november-9-2016/,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : IRWD-US : November 9, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report",2016-11-07 21:48:45 +0000,http://biz.yahoo.com/e/161107/irwd10-q.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood (IRWD) Posts Narrower-than-Expected Loss in Q3,2016-11-04 15:12:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/syv0Nw7FiZU/ironwood-irwd-posts-narrower-than-expected-loss-in-q3-cm703958,Ironwood Pharmaceuticals Inc IRWD reported an adjusted loss of 18 cents per share in the third quarter of 2016 narrower than both the Zacks Consensus Estimate of a loss of 23 cents and the year ago loss of 25 cents FindTheCompany Graphiq Total revenue in the
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood (IRWD) Posts Narrower-than-Expected Loss in Q3,2016-11-04 13:31:01 +0000,http://finance.yahoo.com/news/ironwood-irwd-posts-narrower-expected-133101557.html,Ironwood (IRWD) Posts Narrower-than-Expected Loss in Q3
IRWD,IRWD:UW,BBG000GBZJP0,Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns,2016-11-04 05:17:09 +0000,http://www.insidermonkey.com/blog/mallinckrodt-plc-mnk-depomed-inc-depo-helped-consonance-capital-to-massive-q3-returns-484890/,Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns
IRWD,IRWD:UW,BBG000GBZJP0,Edited Transcript of IRWD earnings conference call or presentation 3-Nov-16 12:30pm GMT,2016-11-03 17:53:05 +0000,http://finance.yahoo.com/news/edited-transcript-irwd-earnings-conference-175305375.html,Edited Transcript of IRWD earnings conference call or presentation 3-Nov-16 12:30pm GMT
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today,2016-11-03 12:30:00 +0000,http://biz.yahoo.com/cc/5/154975.html,Ironwood Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements",2016-11-03 12:21:48 +0000,http://biz.yahoo.com/e/161103/irwd8-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Provides Third Quarter 2016 Investor Update,2016-11-03 12:18:10 +0000,http://www.publicnow.com/view/49A880A62AF68D01E452131F8E0A07896DEA7D51,"[at noodls] - November 3, 2016 - Ironwood revenue increased 67% to $66 million in 3Q 2016 over 3Q 2015 - - Linzess (linaclotide) U.S. net sales increased 40% to $164 million in 3Q 2016 over 3Q 2015; net profit for the ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood reports 3Q loss,2016-11-03 12:16:20 +0000,http://sg.finance.yahoo.com/news/ironwood-reports-3q-loss-121620752.html,Ironwood reports 3Q loss
IRWD,IRWD:UW,BBG000GBZJP0,Q3 2016 Ironwood Pharmaceuticals Inc Earnings Release - After Market Close,2016-11-03 11:07:07 +0000,http://biz.yahoo.com/research/earncal/20161103.html?t=irwd,Q3 2016 Ironwood Pharmaceuticals Inc Earnings Release - After Market Close
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Credit Suisse 25th Annual Healthcare Conference,2016-11-01 20:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-credit-suisse-200100584.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. will present a corporate update at the Credit Suisse 25th Annual Healthcare Conference on Tuesday, November 8th, 2016 at 2:00 p.m. Mountain Time/4:00 p.m."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Highlights Breadth of Gout Research with Presentations at the American College of Rheumatology 2016 Annual Meeting,2016-10-25 12:00:00 +0000,http://finance.yahoo.com/news/ironwood-highlights-breadth-gout-research-120000839.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. today announced a series of oral and poster presentations to be presented at the upcoming American College of Rheumatology Annual Meeting in Washington, D.C."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Host Third Quarter 2016 Investor Update Call,2016-10-20 20:19:18 +0000,http://www.publicnow.com/view/5984F68AF59E542F3612A9625ECF9A8A42DDA6DB,"[at noodls] - October 20, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its third quarter 2016 investor update conference call and webcast at 8:30 ..."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : October 14, 2016",2016-10-14 12:52:51 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-irwd-us-october-14-2016/,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : October 14, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,"ETF’s with exposure to Ironwood Pharmaceuticals, Inc. : October 11, 2016",2016-10-11 14:29:26 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-october-11-2016/,"ETF’s with exposure to Ironwood Pharmaceuticals, Inc. : October 11, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,"Nine in Ten Physicians Agree Target Goal for Gout Is Imperative, Yet Half of Patients Fail to Reach It, New Survey Shows",2016-10-03 12:16:08 +0000,http://www.publicnow.com/view/220FDA249AF9BFC4A642EF416B7D0E023C5861DB,"[at noodls] - October 3, 2016 Physicians frustrated, advocate for aggressive treatment for gout patients, yet target goal of sUA CAMBRIDGE, Mass.--(BUSINESS WIRE)-- A new survey conducted among primary care physicians ..."
IRWD,IRWD:UW,BBG000GBZJP0,"Nine in Ten Physicians Agree Target Goal for Gout Is Imperative, Yet Half of Patients Fail to Reach It, New Survey Shows",2016-10-03 12:00:00 +0000,http://finance.yahoo.com/news/nine-ten-physicians-agree-target-120000324.html,"[Business Wire] - A new survey conducted among primary care physicians and rheumatologists found that despite their overall agreement that gout is a serious and chronic medical condition with potential long-term consequences, patients remain at risk."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Announces U.S. Availability of ZURAMPIC® (lesinurad) 200 mg Tablets for Patients with Uncontrolled Gout,2016-10-03 11:46:04 +0000,http://www.publicnow.com/view/4CF5B1775809BB5FE2D65769EF0A2A37D9DAB13B,"[at noodls] - October 3, 2016 - In clinical studies, ZURAMPIC in combination with allopurinol nearly doubled the number of patients who achieved target serum uric acid (sUA) levels at month 6 compared to patients who ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Closes $150 Million Debt Refinancing,2016-09-26 12:19:04 +0000,http://www.publicnow.com/view/BD2ACFA6E0AFF87AC732032B9F9913F8B9BD90E1,"[at noodls] - September 26, 2016 - Proceeds will be used to redeem all outstanding Linaclotide PhaRMA11% Notes - - Refinancing reduces cost of capital with interest rate of 8.375% - - Transaction expected to fund in ..."
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin",2016-09-26 12:13:31 +0000,http://biz.yahoo.com/e/160926/irwd8-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin"
IRWD,IRWD:UW,BBG000GBZJP0,BTIG Raises Ironwood Pharmaceuticals Price Target Ahead Of New Drug Launch,2016-09-22 15:31:36 +0000,http://finance.yahoo.com/news/btig-raises-ironwood-pharmaceuticals-price-153136683.html,BTIG Raises Ironwood Pharmaceuticals Price Target Ahead Of New Drug Launch
IRWD,IRWD:UW,BBG000GBZJP0,Interesting IRWD Put And Call Options For May 2017,2016-09-20 16:22:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3UKhz261nKM/interesting-irwd-put-and-call-options-for-may-2017-cm682026,Investors in Ironwood Pharmaceuticals Inc Symbol IRWD saw new options begin trading this week for the May 2017 expiration One of the key inputs that goes into the price an option buyer is willing to pay is the time value so with 241 days until expiration the newly trading
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : September 14, 2016",2016-09-14 16:50:29 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-value-analysis-nasdaqirwd-september-14-2016/,"Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : September 14, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : IRWD-US : September 13, 2016",2016-09-13 12:09:43 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-irwd-us-september-13-2016/,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : IRWD-US : September 13, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference,2016-09-07 15:40:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-morgan-stanley-154000160.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 9:55 a.m. Eastern Time at the Grand Hyatt in New York."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Wells Fargo 2016 Healthcare Conference,2016-09-01 20:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-present-wells-fargo-200100191.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. will present a corporate update at the Wells Fargo 2016 Healthcare Conference on Wednesday, September 7, 2016 at 2:20 p.m. Eastern Time at the Westin Waterfront Hotel in Boston."
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : August 31, 2016",2016-08-31 12:13:36 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-irwd-us-august-31-2016/,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : August 31, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,"ETF’s with exposure to Ironwood Pharmaceuticals, Inc. : August 29, 2016",2016-08-29 15:38:28 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-august-29-2016/,"ETF’s with exposure to Ironwood Pharmaceuticals, Inc. : August 29, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,"ETF’s with exposure to Ironwood Pharmaceuticals, Inc. : August 10, 2016",2016-08-10 19:37:23 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-ironwood-pharmaceuticals-inc-august-10-2016/,"ETF’s with exposure to Ironwood Pharmaceuticals, Inc. : August 10, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016",2016-08-09 15:26:52 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-irwd-us-earnings-analysis-q2-2016-by-the-numbers-august-9-2016/,"Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : August 9, 2016",2016-08-09 12:15:33 +0000,http://www.capitalcube.com/blog/index.php/ironwood-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-irwd-us-august-9-2016/,"Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : August 9, 2016"
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report",2016-08-08 21:29:14 +0000,http://biz.yahoo.com/e/160808/irwd10-q.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report"
IRWD,IRWD:UW,BBG000GBZJP0,"Health Care Sector Update for 08/08/2016: PTI,MEIP,CHEK",2016-08-08 20:12:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tn5YQbChcxs/health-care-sector-update-for-08082016-ptimeipchek-cm662070,"Top Health Care Stocks JNJ 0.55% PFE 1.63% MRK 0.71% ABT 1.89% AMGN 0.87% Health care stocks were sharply lower during late Monday trading, with the NYSE Health Care Index sinking about 1.1% while shares of health care companies"
IRWD,IRWD:UW,BBG000GBZJP0,Edited Transcript of IRWD earnings conference call or presentation 4-Aug-16 8:30pm GMT,2016-08-05 01:43:31 +0000,http://finance.yahoo.com/news/edited-transcript-irwd-earnings-conference-014331143.html,Edited Transcript of IRWD earnings conference call or presentation 4-Aug-16 8:30pm GMT
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood reports 2Q loss,2016-08-04 22:45:46 +0000,http://sg.finance.yahoo.com/news/ironwood-reports-2q-loss-224546426.html,Ironwood reports 2Q loss
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update,2016-08-04 20:22:34 +0000,http://www.publicnow.com/view/A16320CB11366037A1960018FB55FBA8022FDC4D,"[at noodls] - August 4, 2016 - Ironwood revenue increased 96% to $54.4 million in 2Q 2016 compared to 2Q 2015 - - LINZESS (linaclotide) U.S. net sales increased 34% to $150.5 million in 2Q 2016 over 2Q 2015; net profit ..."
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements",2016-08-04 20:19:15 +0000,http://biz.yahoo.com/e/160804/irwd8-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements"
IRWD,IRWD:UW,BBG000GBZJP0,Q2 2016 Ironwood Pharmaceuticals Inc Earnings Release - After Market Close,2016-08-04 11:07:06 +0000,http://biz.yahoo.com/research/earncal/20160804.html?t=irwd,Q2 2016 Ironwood Pharmaceuticals Inc Earnings Release - After Market Close
IRWD,IRWD:UW,BBG000GBZJP0,Catalyst (CPRX) Q2 Earnings: Can the Stock Pull a Surprise?,2016-08-04 00:51:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hdMI5idnt0I/catalyst-cprx-q2-earnings-can-the-stock-pull-a-surprise-cm660065,"Catalyst Pharmaceuticals, Inc . CPRX is scheduled to report second quarter 2016 results on Aug 9. Catalyst has maintained an impressive track record so far. The company reported narrower than expected losses in two of the last four quarters,"
IRWD,IRWD:UW,BBG000GBZJP0,Why Ironwood Pharmaceuticals (IRWD) Might Surprise This Earnings Season,2016-08-03 14:58:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kEvWGAM3Cwc/why-ironwood-pharmaceuticals-irwd-might-surprise-this-earnings-season-cm659556,"Investors are always looking for stocks that are poised to beat at earnings season and Ironwood Pharmaceuticals, Inc. IRWD may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely"
IRWD,IRWD:UW,BBG000GBZJP0,Why Ironwood Pharmaceuticals (IRWD) Might Surprise This Earnings Season,2016-08-03 12:59:12 +0000,http://finance.yahoo.com/news/why-ironwood-pharmaceuticals-irwd-might-125912027.html,Why Ironwood Pharmaceuticals (IRWD) Might Surprise This Earnings Season
IRWD,IRWD:UW,BBG000GBZJP0,What Awaits Radius Health (RDUS) this Earnings Season?,2016-08-02 15:59:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yx_b07gVtA0/what-awaits-radius-health-rdus-this-earnings-season-cm658822,"Radius Health, Inc.RDUS is scheduled to report second quarter 2016 results on Aug 4. Last quarter, the company recorded a negative earnings surprise of 13.25%. Let's see how things are shaping up for the company this quarter.Factors Influencing This"
IRWD,IRWD:UW,BBG000GBZJP0,What's in Store for Merck KGaA (MKGAF) in Q2 Earnings?,2016-08-02 15:59:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QrjniFp9hYY/whats-in-store-for-merck-kgaa-mkgaf-in-q2-earnings-cm658811,"Merck KGaAMKGAF is scheduled to report second quarter 2016 earnings results on Aug 4. Let's see how things are shaping up for this quarter. The company reports results under three business sectors Healthcare, Life Science and Performance Materials. Strong"
IRWD,IRWD:UW,BBG000GBZJP0,Intercept (ICPT) Likely to Beat in Q2 Earnings: Stock to Gain?,2016-08-02 13:57:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ykexZb_vpgQ/intercept-icpt-likely-to-beat-in-q2-earnings-stock-to-gain-cm658774,"Intercept Pharmaceuticals, Inc.ICPT is scheduled to report second quarter 2016 results on Aug 4. Intercept has a mixed track record so far, with the company missing estimates in two of the last four quarters. However, it has posted an"
IRWD,IRWD:UW,BBG000GBZJP0,What Awaits Aerie Pharmaceuticals (AERI) in Q2 Earnings?,2016-08-02 00:52:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mE9KUKlHsPI/what-awaits-aerie-pharmaceuticals-aeri-in-q2-earnings-cm658490,"Aerie Pharmaceuticals, Inc.AERI is scheduled to report second quarter 2016 results after the market closes on Aug 3. Aerie's performance over the last four quarters has been disappointing. The company reported a wider than expected loss thrice in the"
IRWD,IRWD:UW,BBG000GBZJP0,Merrimack (MACK): Can the Stock Surprise in Q2 Earnings?,2016-08-02 00:52:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jF_XHcmbOiI/merrimack-mack-can-the-stock-surprise-in-q2-earnings-cm658488,"Merrimack Pharmaceuticals, Inc.MACK is scheduled to report second quarter 2016 results on Aug 4. Last quarter, Merrimack delivered an earnings surprise of +15.38%. Let's see how things are shaping up for the company this quarter.Factors Influencing This Quarter Merrimack's"
IRWD,IRWD:UW,BBG000GBZJP0,Exelixis (EXEL) Q2 Earnings Preview: Stock Likely to Gain?,2016-08-01 17:56:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W3MjYuHZMSI/exelixis-exel-q2-earnings-preview-stock-likely-to-gain-cm658210,"Exelixis, Inc . EXEL is scheduled to report second quarter 2016 results on Aug 3 after the market closes . Exelixis has a disappointing track record over the last four quarters. The company surpassed expectations only once in the"
IRWD,IRWD:UW,BBG000GBZJP0,Aegerion (AEGR): What Awaits for the Stock in Q2 Earnings?,2016-08-01 15:57:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H0ltnvH1w-s/aegerion-aegr-what-awaits-for-the-stock-in-q2-earnings-cm658042,"Aegerion Pharmaceuticals, Inc.AEGR is expected to report second quarter 2016 results on Aug 3. Last quarter, Aegerion recorded a negative earnings surprise of 242.59%. Let's see how things are shaping up for the company this quarter.Factors at Play Although"
IRWD,IRWD:UW,BBG000GBZJP0,Sam Isaly Swaps 3 Health Care Stocks in Second Quarter,2016-07-29 23:23:14 +0000,http://finance.yahoo.com/news/sam-isaly-swaps-3-health-232314775.html,Sam Isaly Swaps 3 Health Care Stocks in Second Quarter
IRWD,IRWD:UW,BBG000GBZJP0,Keryx (KERX) Q2 Earnings Preview: Will the Stock Gain?,2016-07-29 23:21:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ex1VT8hoVg/keryx-kerx-q2-earnings-preview-will-the-stock-gain-cm657618,"Keryx Biopharmaceuticals, Inc.KERX is expected to report second quarter 2016 results on Aug 3. Keryx's track record has been disappointing so far. Over the four trailing quarters, the company posted an average negative earnings surprise of 16.50%, having met"
IRWD,IRWD:UW,BBG000GBZJP0,What's in Store for Prothena (PRTA) This Earnings Season?,2016-07-29 22:25:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6Eq9TgzTCZs/whats-in-store-for-prothena-prta-this-earnings-season-cm657587,"Prothena Corporation plcPRTA is expected to report second quarter 2016 results on Aug 2. Prothena's track record has been has dismal so far. Over the four trailing quarters, the company's earnings have missed estimates thrice and beat the same"
IRWD,IRWD:UW,BBG000GBZJP0,Whta's in Store for Endocyte (ECYT) this Earnings Season?,2016-07-28 17:28:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nQqdaZ6Qzv4/whtas-in-store-for-endocyte-ecyt-this-earnings-season-cm656672,"Endocyte, Inc . ECYT is expected to report second quarter 2016 results on Aug 2. Endocyte has an impressive track record. The company has beaten estimates in three of the last four quarters and met the same in the"
IRWD,IRWD:UW,BBG000GBZJP0,Mallinckrodt (MNK) Q3 Earnings: Will the Stock Surprise?,2016-07-28 01:22:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QtCyMgBqWJo/mallinckrodt-mnk-q3-earnings-will-the-stock-surprise-cm656136,"Mallinckrodt plcMNK is set to report third quarter fiscal 2016 results on Aug 2. The company's track record has been impressive so far. It has beaten estimates in all of the last four quarters, with a positive average earnings"
IRWD,IRWD:UW,BBG000GBZJP0,AmerisourceBergen (ABC) Q3 Earnings: Stock to Surprise?,2016-07-27 18:25:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AlHAQBDJxuE/amerisourcebergen-abc-q3-earnings-stock-to-surprise-cm655849,"AmerisourceBergen CorporationABC is set to report third quarter fiscal 2016 results on Aug 2, before the opening bell. AmerisourceBergen's track record has been quite impressive, with the company comfortably beating estimates in three of the four trailing quarters. In"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Host Second Quarter 2016 Investor Update Call,2016-07-21 20:01:00 +0000,http://finance.yahoo.com/news/ironwood-pharmaceuticals-host-second-quarter-200100193.html,"[Business Wire] - Ironwood Pharmaceuticals, Inc. today announced it will host its second quarter 2016 investor update conference call and webcast at 4:30 p.m. Eastern Time on Thursday, August 4, 2016."
IRWD,IRWD:UW,BBG000GBZJP0,Coverage Initiated on Select Generic Drugs Makers Equities,2016-07-12 13:28:00 +0000,http://news.investornetwork.com/2016/07/12/coverage-initiated-on-select-generic-drugs-makers-equities/?1=1&1468330080,Coverage Initiated on Select Generic Drugs Makers Equities
IRWD,IRWD:UW,BBG000GBZJP0,"5 Trade Ideas for Tuesday: AstraZeneca, BRF SA, Cerner, Ironwood Pharma and Marathon Oil",2016-07-04 14:38:36 +0000,http://finance.yahoo.com/tumblr/blog-5-trade-ideas-for-tuesday-astrazeneca-brf-sa-143841933.html,"5 Trade Ideas for Tuesday: AstraZeneca, BRF SA, Cerner, Ironwood Pharma and Marathon Oil"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood/Allergan's Linzess sNDA Accepted for FDA Review,2016-06-10 15:31:03 +0000,http://finance.yahoo.com/news/ironwood-allergans-linzess-snda-accepted-153103520.html,Ironwood/Allergan's Linzess sNDA Accepted for FDA Review
IRWD,IRWD:UW,BBG000GBZJP0,"Here's Why Ironwood Pharmaceuticals, Inc. Jumped 19.52% in May",2016-06-09 18:43:00 +0000,http://www.fool.com/investing/general/2016/06/09/heres-why-ironwood-pharmaceuticals-jumped-1952-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Here's Why Ironwood Pharmaceuticals, Inc. Jumped 19.52% in May"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review,2016-06-09 12:49:04 +0000,http://www.publicnow.com/view/B7FAB19B2F3366C58EBAB62DFD5E36199A587DF4,"[at noodls] - CAMBRIDGE, Mass. and DUBLIN, June 9, 2016 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference,2016-06-06 20:18:05 +0000,http://www.publicnow.com/view/1485D3E6F428E66516B71519D354A64A08EB30B7,"[at noodls] - June 6, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Jefferies 2016 Healthcare Conference on Friday, June 10, 2016 at 2:30 ..."
IRWD,IRWD:UW,BBG000GBZJP0,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders",2016-06-03 12:02:18 +0000,http://biz.yahoo.com/e/160603/irwd8-k.html,"IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Closes U.S. Transaction with AstraZeneca for Lesinurad,2016-06-03 06:25:04 +0000,http://www.publicnow.com/view/ABA3185EAC9BD591E5E1C7FC5956C509A4EB1EE7,"[at noodls] - June 3, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that it has closed the previously-announced transaction with AstraZeneca for the exclusive ..."
IRWD,IRWD:UW,BBG000GBZJP0,FTSE 100 Up 50 Points As Commodity-related Stocks Climb,2016-06-03 05:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oDfOIksYmWE/ftse-100-up-50-points-as-commodityrelated-stocks-climb-20160603-00072,FTSE 100 Up 50 Points As Commodity-related Stocks Climb
IRWD,IRWD:UW,BBG000GBZJP0,AstraZeneca Completes US Licensing Pact with Ironwood Pharmaceuticals,2016-06-03 02:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pmyvexkrQQc/astrazeneca-completes-us-licensing-pact-with-ironwood-pharmaceuticals-20160603-00029,AstraZeneca Completes US Licensing Pact with Ironwood Pharmaceuticals
IRWD,IRWD:UW,BBG000GBZJP0,AstraZeneca Completes US Licensing Deal With Ironwood Pharma For Lesinurad,2016-06-03 02:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0pRr7d3KGLU/astrazeneca-completes-us-licensing-deal-with-ironwood-pharma-for-lesinurad-20160603-00025,AstraZeneca Completes US Licensing Deal With Ironwood Pharma For Lesinurad
IRWD,IRWD:UW,BBG000GBZJP0,"AstraZeneca sells EU, Latam gout drug rights to Gruenenthal",2016-06-02 06:52:00 +0000,http://uk.finance.yahoo.com/news/astrazeneca-sells-eu-latam-gout-065200228.html,"AstraZeneca sells EU, Latam gout drug rights to Gruenenthal"
IRWD,IRWD:UW,BBG000GBZJP0,"AstraZeneca: GrÃ¼nenthal To Acquire Rights To Zurampic In EU, Latin-America",2016-06-02 02:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G_9-q80wH-I/astrazeneca-gr%C3%A3nenthal-to-acquire-rights-to-zurampic-in-eu-latin-america-20160602-00045,"AstraZeneca: GrÃ¼nenthal To Acquire Rights To Zurampic In EU, Latin-America"
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference,2016-06-01 21:05:05 +0000,http://www.publicnow.com/view/076B05CC1DF504BC8AF26A82823CE1639EF64FAE,"[at noodls] - June 1, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Goldman Sachs 37 Annual Global Healthcare Conference on Tuesday, June ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at 2016 UBS Global Healthcare Conference,2016-05-18 20:32:05 +0000,http://www.publicnow.com/view/D3D34EFD62D837FBE1F4222AD00D7ED45BF2EA75,"[at noodls] - May 18, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 2016 UBS Global Healthcare Conference on Wednesday, May 25, 2016 at ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood reports 1Q loss,2016-05-09 21:18:39 +0000,http://sg.finance.yahoo.com/news/ironwood-reports-1q-loss-211839314.html,Ironwood reports 1Q loss
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update,2016-05-09 20:18:19 +0000,http://www.publicnow.com/view/5E88AB7693699CA67828577B79C0960D34398CF7,"[at noodls] - May 9, 2016 -Progress across priority opportunities, including two Phase IIb trials underway, and lesinurad license establishes new uncontrolled gout franchise - - LINZESS (linaclotide) U.S. net sales ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2016 Health Care Conference,2016-05-03 20:20:06 +0000,http://www.publicnow.com/view/D00990008F1D169A22A7FFEFB1AA727EFA67D7D3,"[at noodls] - May 3, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Bank of America Merrill Lynch 2016 Health Care Conference onTuesday, ..."
IRWD,IRWD:UW,BBG000GBZJP0,BUZZ-Ironwood Pharma plunges after Phase Five report,2016-04-26 15:39:51 +0000,http://uk.finance.yahoo.com/news/buzz-ironwood-pharma-plunges-phase-153951565.html,BUZZ-Ironwood Pharma plunges after Phase Five report
IRWD,IRWD:UW,BBG000GBZJP0,AstraZeneca sells U.S. gout drug rights to Ironwood for up to $265 million,2016-04-26 10:01:53 +0000,http://sg.finance.yahoo.com/news/astrazeneca-buy-u-rights-gout-090133703.html,AstraZeneca sells U.S. gout drug rights to Ironwood for up to $265 million
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Enters into U.S. Licensing Agreement with AstraZeneca for Lesinurad,2016-04-26 09:21:20 +0000,http://www.publicnow.com/view/5D32DAA41C973FC8A81C330065C98F45461D6EE8,"[at noodls] - April 26, 2016 - Includes FDA-approved ZURAMPIC® (lesinurad), expected to launch second half 2016 for hyperuricemia associated with uncontrolled gout, and lesinurad/allupironol fixed-dose combination - ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Host First Quarter 2016 Investor Update Call,2016-04-25 20:24:05 +0000,http://www.publicnow.com/view/817505D7046971EA61B15DDE58D77C3DA08A9D60,"[at noodls] - April 25, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its first quarter 2016 investor update conference call and webcast at 4:30 ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Appoints Andrew Dreyfus to Board of Directors,2016-04-07 12:12:04 +0000,http://www.publicnow.com/view/D0E5C4539C443185BA0E8917AF8BD306079DBABB,"[at noodls] - April 7, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appointment of Andrew Dreyfus, president and chief executive officer of Blue Cross Blue ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Reports Top-Line Data from Exploratory Phase IIa Study of IW-9179 in Diabetic Gastroparesis,2016-04-05 12:30:14 +0000,http://www.publicnow.com/view/B315017854DC0844A6647ECB5405CFE8E2BDC89B,"[at noodls] - April 5, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that top-line data from an exploratory Phase IIa clinical study indicate IW-9179 did not ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present Clinical and Preclinical Data on sGC Stimulators at Upcoming Scientific Conferences,2016-03-30 12:21:50 +0000,http://www.publicnow.com/view/CFF4170E5C1A7AEFB0BF7787038DDAF5CC62FF9F,"[at noodls] - March 30, 2016 - Data to be presented at American College of Cardiology, Association for Research in Vision and Ophthalmology, and American Thoracic Society - CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Initiates Phase IIb Clinical Trial of IW-3718 in Refractory Gastroesophageal Reflux Disease,2016-03-23 12:25:12 +0000,http://www.publicnow.com/view/063A3B0976796BF2801E32709049DBDA2CAD87DF,"[at noodls] - March 23, 2016 -Demonstrates progress executing strategy to advance at least three new medicines addressing significant unmet needs into later-stage development by 2017/2018- CAMBRIDGE, Mass.--(BUSINESS ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Announces Filing by Astellas of New Drug Application in Japan with Linaclotide for the Treatment of Adults with IBS-C,2016-02-24 13:00:00 +0000,http://au.finance.yahoo.com/news/ironwood-pharmaceuticals-announces-filing-astellas-130000609.html,"[Business Wire] - CAMBRIDGE, Mass.--(BUSINESSWIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - News) today announced that a new drug application (NDA) seeking approval of linaclotide for the treatment of adults with irritable bowel syndrome with constipation (IBS-C) in Japan was filed with the Japanese Ministry of Health, Labor and Welfare by Astellas Pharma Inc., Ironwood’s partner for linaclotide in Japan. Linaclotide is a guanylate cyclase‐C (GC‐C) receptor agonist currently approved, and is the branded prescription market leader, for the treatment of adults with IBS-C or chronic idiopathic constipation (CIC) in the United States, where more than 40 million patients are estimated to suffer from these conditions."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood reports 4Q loss,2016-02-18 22:33:48 +0000,http://sg.finance.yahoo.com/news/ironwood-reports-4q-loss-223348774.html,Ironwood reports 4Q loss
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals Details Strategy to Build Top-Performing Commercial Biotechnology Company,2016-01-11 14:18:04 +0000,http://www.noodls.com/view/ABCF09099A0392628ED7F7F59E7F557BC992D60B,"[at noodls] - January 11, 2016 - At least in LINZESS® (linaclotide) annual net sales expected by 2020; greater than linaclotide peak sales potential - - At least three additional blockbuster opportunities expected to ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference,2016-01-04 21:10:09 +0000,http://www.noodls.com/view/C89EE91E528BD56E747A416B7532B4CBA009321D,"[at noodls] - January 4, 2016 --(BUSINESS WIRE)-- (: IRWD) will present a corporate update at the 34 Annual at / at the in . The presentation will be followed by a question and answer session that will begin at / . ..."
IRWD,IRWD:UW,BBG000GBZJP0,Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan (pdf 505KB),2015-12-01 00:26:17 +0000,http://www.noodls.com/view/C117C0E16AA901AA76116B2A9A1B222CDD20712B,"[at noodls] - a360d55b-c405-4280-a8c9-fbe015352def.pdf FOR IMMEDIATE RELEASE Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan TOKYO & CAMBRIDGE, Mass., Nov 30, 2015 - ..."
IRWD,IRWD:UW,BBG000GBZJP0,Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan,2015-11-30 21:13:30 +0000,http://www.noodls.com/view/30CA3244775E1937EDD2AC7899D35197C982938F,"[at noodls] - November 30, 2015 TOKYO & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Astellas Pharma Inc. (TSE: 4503) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that the Phase III clinical trial of linaclotide ..."
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood reports 3Q loss,2015-11-03 22:25:50 +0000,http://sg.finance.yahoo.com/news/ironwood-reports-3q-loss-222550000.html,Ironwood reports 3Q loss
IRWD,IRWD:UW,BBG000GBZJP0,Ironwood beats 3Q profit forecasts,2014-11-04 23:42:46 +0000,http://sg.finance.yahoo.com/news/ironwood-beats-3q-profit-forecasts-234246940--finance.html,Ironwood beats 3Q profit forecasts
